Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Final Blow For Dendreon?
Seeking Alpha
Thursday, September 6, 2012 - 9:30am
tags:
Dendreon, JNJ, Xtandi, Medivation
Jazz Pharmaceuticals is selling women's health business to Meda for $95 million
Yahoo/AP
Thursday, September 6, 2012 - 9:24am
tags:
Jazz Pharmaceuticals, Women's Health, M&A, media
Abbott's Humira: A Drug To Buy Into
Seeking Alpha
Thursday, September 6, 2012 - 9:22am
tags:
Abbott Labs, Humira, JNJ, Merck
Pain-Free Pipeline Progress
Motley Fool
Thursday, September 6, 2012 - 9:21am
tags:
Exalgo, Zalicus, Z160
Hi-Tech Pharm misses badly
Yahoo/Investors Business Daily
Thursday, September 6, 2012 - 9:19am
tags:
Hi-Tech Pharmacal, earnings
High-End HIV Drug Stribild To Set Gilead Sciences Apart
Seeking Alpha
Wednesday, September 5, 2012 - 6:56pm
tags:
HIV, Gilead, Stribild
Ampio's New Anti-Inflammatory Drug May Achieve Rapid FDA Clearance
Seeking Alpha
Wednesday, September 5, 2012 - 6:53pm
tags:
Ampio, FDA, Abbott Labs, JNJ, Amgen, Pfizer, Ampion, osteoarthritis
Are Alzheimer’s Drugs Catalyzing These Stock Prices?
Wall St. Cheat Sheet
Wednesday, September 5, 2012 - 6:51pm
tags:
Alzheimer's disease, solanezumab, Pfizer, JNJ, Eli Lilly
Is This Biotech's Shortened Study Good Enough for Approval?
Motley Fool
Wednesday, September 5, 2012 - 6:50pm
tags:
BioSante, LibiGel
4 Big Reasons to Buy Merck
Motley Fool
Wednesday, September 5, 2012 - 6:49pm
tags:
Merck
Pharmacyclics posts wider fiscal 4th-quarter loss
Yahoo/AP
Wednesday, September 5, 2012 - 6:49pm
tags:
earnings, Pharmacyclics
How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse
Forbes
Wednesday, September 5, 2012 - 12:51pm
tags:
Alexion, Soliris, anemia
5 BioPharmas To Watch For Wednesday, September 5
Seeking Alpha
Wednesday, September 5, 2012 - 12:46pm
tags:
Amarin, GSK, BioSante, NovaBay Pharmaceuticals, Santarus, Sarepta
A Successful Phase 2b Study Isn't As Meaningful As It Used To Be
Forbes
Wednesday, September 5, 2012 - 12:41pm
tags:
clinical trials, Resverlogix, RVX-208
FDA Sued By Consumer Group Over Alzheimer Drug Dosage
Bloomberg
Wednesday, September 5, 2012 - 12:39pm
tags:
FDA, Alzheimer's disease, Aricept, Public Citizen
Amarin issues patent update on fish-oil drug
Marketwatch
Wednesday, September 5, 2012 - 12:37pm
tags:
Amarin, patents, fish oil, Vascepa
FDA sets priority review for J&J tuberculosis drug
Yahoo/AP
Wednesday, September 5, 2012 - 11:53am
tags:
JNJ, tuberculosis, FDA, TMC207
Eli Lilly: New Drug Nightmares Will Sink Stock In 2013
Seeking Alpha
Wednesday, September 5, 2012 - 11:50am
tags:
Eli Lilly, Teva Pharmaceuticals, Pfizer, Mylan, Bristol-Myers Squibb
Roche Vows To Keep Up R&D Spend, Go Beyond Cancer Therapies
NASDAQ.com
Wednesday, September 5, 2012 - 10:58am
tags:
Roche, R&D
Glaxo Studies Three-In-One Emphysema Medicine to Keep Lead
Bloomberg Businessweek
Wednesday, September 5, 2012 - 10:57am
tags:
GSK, emphysema, GSK961081

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.